3 FTSE 100 dividend stocks yielding 5%+ I’d buy for a new SIPP

Roland Head reveals his three top FTSE 100 (INDEXFTSE:UKX) picks for a starter pension portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I wouldn’t ever suggest running a stock portfolio with just three shares. But if I did, I think the three companies I’m looking at today would give you a good chance of a reliable dividend income and long-term gains. They could be ideal choices for a Self-Invested Personal Pension (SIPP).

All three firms operate in business sectors that are part of the fabric of life in most developed economies. And all three are among the largest in their market sectors, with significant market share and financial firepower.

In other words, I think there’s a strong likelihood that all three of these companies will remain in business for longer than I’ll need my pension.

Staying healthy

First up is FTSE 100 pharma giant GlaxoSmithKline (LSE: GSK). Shares in this firm have pulled back a little recently, despite the firm upgrading its full-year profit guidance in July. In my view this has opened up a potential buying opportunity.

Glaxo’s portfolio includes valuable consumer health products and a wide range of medicines. The consumer health division may be spun off at some point to leave a more focused pharmaceutical group. But whether this happens or not, I think the outlook is good for shareholders.

Cost savings and growth in areas such as vaccines are helping to restore the group’s cash flow. And a recent press report suggests that Coca-Cola might be considering a £3bn bid for the firm’s Horlicks business, which is big in India.

In my view, the stock’s forecast price/earnings ratio of 13.5 and 5.4% yield make GlaxoSmithKline a buy for income and long-term growth.

A one-stop shop

I’ve long rated commodities group BHP Billiton (LSE: BLT) as a top buy for investors wanting a reliable income from the commodities sector.

Because the firm operates in the oil and gas sector as well as in mining, investors get exposure to a diversified mix of commodities. Good quality assets and strong management mean that the firm’s profit margins are among the highest in the sector.

Net debt has fallen rapidly since the mining downturn and the group’s balance sheet looks bullet-proof to me. Free cash flow came in at £9.6bn last year, putting the stock on a cheap-looking price/free cash flow ratio of 8.3.

Strong cash generation provides good support for the dividend, which is expected to provide a yield of 6.5% this year. I rate BHP Billiton as a buy at current levels.

A moving picture

My final choice is television group ITV (LSE: ITV).There has been a lot of talk about declining advertising revenue and the shift to online subscription services like Netflix. But ITV has countered these challenges by building up its ITV Studios business, which produces programmes for the group’s own channels and licences it to other broadcasters.

Studios revenue rose by 16% during H1 and this division now generates more than half of all sales. Despite this, falling ad revenues have caused profits to slip over the last couple of years. Analysts have pencilled in a drop to 15.5p per share this year with flat earnings in 2019.

In my view, the bad news is already in the share price. I think the market will soon start to look further ahead. And with the shares now trading on just 10 times forecast earnings with a 5% dividend yield, I think it’s time to buy ITV.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Netflix. The Motley Fool UK has recommended ITV. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »